Maintenance doses for Zepbound are typically 5 mg, 10 mg, or 15 mg weekly
Research has demonstrated no significant changes in fasting glucose or insulin sensitivity in subjects using the peptide
Perez Cuevas MB, Kodani M, Choi Y, Joyce J, OConnor SM, Kamili S, Prausnitz MR
This happens because of how the drug works in the body and is expected
GLP-1 (Glucagon-like Peptide-1) A hormone that stimulates insulin release, slows stomach emptying, and reduces appetite
CBC also reported that Ozempic has more than 200,000 country-wide beneficiaries on public drug plans, citing a federal report